Monitor for subsequent Form 4 filings confirming actual sales. The large proposed sale by a major institutional affiliate suggests potential near-term selling pressure. Traders should watch for accelerated execution through Goldman Sachs and consider the overhang on CELC's stock price.
Price Chart
Executive Summary
Baker Brothers affiliates (667, L.P. and Baker Brothers Life Sciences L.P.) filed Form 144 notices to sell a combined 3,100,000 shares of Celcuity Inc. common stock, valued at approximately $317.75 million. This represents about 6.35% of outstanding shares and signals a significant reduction in exposure by a major healthcare-focused institutional investor.
Key Facts
- 667, L.P. intends to sell 261,368 shares worth ~$26.79 million.
- Baker Brothers Life Sciences L.P. intends to sell 2,838,632 shares worth ~$290.96 million.
- Combined proposed sale: 3,100,000 shares, approximately $317.75 million (6.35% of outstanding shares).
- Shares were purchased between 12/13/2024 and 5/16/2025 in open market transactions.
- Filing signed by Scott L. Lessing, President of Baker Bros. Advisors LP, the investment adviser to both entities.
Financial Impact
Approximately $317.75 million of stock to be sold, representing ~6.35% of outstanding shares (based on 48,766,288 shares outstanding noted in the filing).
Risk Factors
- Large block sale could depress share price if executed rapidly.
- Signals reduced conviction from a knowledgeable long-term investor (Baker Brothers).
- Remaining 93.65% of shares still held by other insiders/institutions, but this sale is material.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (CELC) — Batch item 1 | 0001104659-26-083659 |
| Document: 0001104659-26-083659-index.html | 0001104659-26-083657 |
| Document: 0001104659-26-083659.txt | 0001104659-26-083659 |
| 144 Filing (CELC) — Batch item 4 | 0001104659-26-083657 |
| Document: 0001104659-26-083657-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083657.txt | 0001104659-26-083659 |
| 144 Filing (CELC) — Batch item 7 | 0001104659-26-083659 |
| Document: 0001104659-26-083659-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083659.txt | 0001104659-26-083659 |
| 144 Filing (CELC) — Batch item 10 | 0001104659-26-083657 |
| Document: 0001104659-26-083657-index.html | 0001104659-26-083659 |
| Document: 0001104659-26-083657.txt | 0001104659-26-083659 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 26, 2026 5w ago | 8-K | $95.08 $84.00 | ▼ −11.65% | ▼ −12.86% | $72.51 (−23.74%) |
Jul 15, 2026 11w ago | 144 | $91.51 $92.08 | ▼ −0.62% | ▲ +1.72% | $72.51 (+20.76%) |
Jul 14, 2026 11w ago | Press Release | $91.51 $92.08 | ▲ +0.62% | ▼ −1.72% | $72.51 (−20.76%) |
Jun 11, 2026 16w ago | Institutional Cluster | $89.49 $113.51 | ▲ +26.84% | ▲ +24.95% | $72.51 (−18.97%) |
Jun 8, 2026 16w ago | 8-K | $92.59 $115.72 | ▲ +24.98% | ▲ +23.53% | $72.51 (−21.69%) |
Jun 5, 2026 17w ago | 424B5 | $88.28 $108.58 | ▲ +23.00% | ▲ +21.13% | $72.51 (−17.86%) |
Jun 4, 2026 17w ago | Press Release | $92.47 $107.95 | ▲ +16.74% | ▲ +18.11% | $72.51 (−21.59%) |
Jun 3, 2026 17w ago | Press Release | $88.95 $107.95 | ▼ −21.36% | ▼ −22.36% | $72.51 (+18.48%) |
Jun 3, 2026 17w ago | 424B5 | $88.95 $107.95 | ▼ −21.36% | ▼ −22.36% | $72.51 (+18.48%) |
Jun 2, 2026 17w ago | 8-K | $91.42 $104.49 | ▲ +14.30% | ▲ +15.86% | $72.51 (−20.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access